Figure_8.tif (1.67 MB)
Luteolin inhibited the activation of AKT/ERK/mTOR/p70S6K/MMP-2/MMP-9 pathway in prostate cancer cells.
figure
posted on 2013-02-19, 17:48 authored by Poyil Pratheeshkumar, Young-Ok Son, Amit Budhraja, Xin Wang, Songze Ding, Lei Wang, Andrew Hitron, Jeong-Chae Lee, Donghern Kim, Sasidharan Padmaja Divya, Gang Chen, Zhuo Zhang, Jia Luo, Xianglin ShiLuteolin inhibited the activation of AKT/ERK/mTOR/p70S6K/MMP-2/MMP-9 pathway in PC-3 cells. Proteins from different treatments was tested by Western blotting and probed with specific antibodies. Experiments were repeated for three times.
